Showing results (201-210 of 259) with videos related to

Sort By:
Pageof 26
Breast Cancer Research and Treatment|January 29, 2014
Pure anti-tumor effect of zoledronic acid in naïve bone-only metastatic and locally advanced breast cancer: proof from the "biological window therapy"Chiara Foroni, Manuela Milan, Carla Strina, et al.
JNCI Cancer Spectrum|August 12, 2025
Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysisFrancesco Schettini, Sabrina Nucera, Giuseppe Di Grazia, et al.
Cancers|April 3, 2021
Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-AnalysisFrancesco Schettini, Mario Giuliano, Fabiola Giudici, et al.
Phytotherapy Research : PTR|June 26, 2024
Anti-inflammatory and anti-hyperalgesic effects induced by an aqueous aged black garlic extract in rodent models of ulcerative colitis and colitis-associated visceral painMaria Loreta Libero, Elena Lucarini, Lucia Recinella, et al.
Cancer Treatment Reviews|December 22, 2024
Efficacy and safety of antibody-drug conjugates in pretreated HER2-low metastatic breast cancer: A systematic review and network meta-analysisFrancesco Schettini, Sabrina Nucera, Tomás Pascual, et al.
Tumori|October 10, 2014
Efficacy of trastuzumab in unselected patients with HER2-positive metastatic breast cancer: a retrospective analysisElena Collovà, Antonella Ferzi, Giuseppa Scandurra, et al.
Cells|April 12, 2024
CD99 Expression and Prognostic Impact in Glioblastoma: A Single-Center Cohort StudyAndrea Rocca, Fabiola Giudici, Carmine Antonio Donofrio, et al.
European Journal of Cancer (Oxford, England : 1990)|October 31, 2025
International expert consensus on the clinical integration of circulating tumor cells in solid tumorsEleonora Nicolò, Carolina Reduzzi, Jean-Yves Pierga, et al.
Cancers|October 14, 2022
BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-MakingFrancesco Pavese, Ettore Domenico Capoluongo, Margherita Muratore, et al.
JNCI Cancer Spectrum|December 19, 2023
Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancerMarina Elena Cazzaniga, Foluso Ademuyiwa, Thierry Petit, et al.
Pageof 26